A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
- Resource Type
- Article
- Authors
- Rao, V. Koneti; Webster, Sharon; Šedivá, Anna; Plebani, Alessandro; Schuetz, Catharina; Shcherbina, Anna; Conlon, Niall; Coulter, Tanya; Dalm, Virgil A.; Trizzino, Antonino; Zharankova, Yulia; Kulm, Elaine; Körholz, Julia; Lougaris, Vassilios; Rodina, Yulia; Radford, Kath; Bradt, Jason; Kucher, Klaus; Relan, Anurag; Holland, Steven M.; Lenardo, Michael J.; Uzel, Gulbu
- Source
- In Blood 2 March 2023 141(9):971-983
- Subject
- Plenary Papers
Clinical Trials and Observations
Immunobiology and Immunotherapy
Free Research Articles
- Language
- ISSN
- 0006-4971